Guacetisal
![]() | |
| Clinical data | |
|---|---|
| Trade names | Broncaspin; Balsacetil; Guaiaspir; Prontomucil |
| ATC code | N02BA14 (WHO) |
| Identifiers | |
| |
| Synonyms | Aspirin guaiacol ester; O-Methoxyphenyl salicylate acetate |
| CAS Number | 55482-89-8 |
| PubChem (CID) | 68749 |
| ChemSpider | 61994 |
| ChEMBL | CHEMBL2105097 |
| ECHA InfoCard | 100.054.221 |
| Chemical and physical data | |
| Formula | C16H14O5 |
| Molar mass | 286.279 g/mol |
| 3D model (Jmol) | Interactive image |
| Melting point | 72 to 74.5 °C (161.6 to 166.1 °F) |
| |
| |
Guacetisal is a drug that has been used to treat inflammatory respiratory diseases.[1] Chemically, it is an ester resulting from the combination of aspirin and guaiacol.
References
| Pyrazolones / Pyrazolidines | |
|---|---|
| Salicylates | |
| Acetic acid derivatives and related substances | |
| Oxicams | |
| Propionic acid derivatives (profens) |
|
| N-Arylanthranilic acids (fenamates) | |
| Coxibs | |
| Other | |
Items listed in bold indicate initially developed compounds of specific groups. #WHO-EM †Withdrawn drugs. ‡Veterinary use medications. | |
This article is issued from Wikipedia - version of the 7/2/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
